Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA

Author： Borges Anna  

Publisher： Springer Publishing Company

ISSN： 2210-7703

Source： International Journal of Clinical Pharmacy, Vol.35, Iss.3, 2013-06, pp. : 425-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unlicensed and off-label drug use in children: implications for safety

By Choonara Imti  

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 81-83

Informa Healthcare

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use in Children: Implications for Safety

By Choonara I.   Conroy S.  

Drug Safety, Vol. 25, Iss. 1, 2002-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

FDA recommends against off-label sildenafil use in children

By  

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use: Issues and Recommendations

By Conroy S.  

Pediatric Drugs, Vol. 4, Iss. 6, 2002-01 ,pp. : 353-359

Adis International

Access to resources Recommend Favorite

Off-label and unlicensed use of antidotes in paediatric patients

By Lifshitz Matityahu   Gavrilov Vladimir   Gorodischer Rafael  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 839-841

Springer Publishing Company

Access to resources Recommend Favorite